Skip to content

CDR

Rite Aid board selects 1-for-20 of reverse stock split ratio

Rite Aid Corp. announced that its board of directors has approved a reverse stock split of the company’s common stock at a ratio of 1-for-20. The reverse stock split was previously approved by stockholders at a Special Meeting of Stockholders held on March 21, 2019.

CBDfx rolls out new dissolving CBD mouth strips

CBD innovators CBDfx announced Wednesday the launch of a frequently requested dosing method: dissolving CBD mouth strips. This new line of CBD edibles represents the growing California company’s dedication to fulfilling customer desires through new product development.

Walgreens, VillageMD to offer primary care services

Walgreens and VillageMD, a leading national provider of primary care, Wednesday announced a collaboration focused on providing adult patients in the Houston community with a transformative primary care experience.

Embrace Active Scar Defense now available at Walgreens stores nationwide

Neodyne Biosciences Tuesday announced that the Embrace family of scar therapy products is now available in Walgreens drugstores nationwide and on Walgreens.com. The leading drugstore retailer in the U.S. has partnered with Neodyne to offer embrace in their first aid aisle.

PBMs advocate for consumers and health plans to reduce Rx drug costs

Pharmaceutical Care Management Association (PCMA) president and chief executive officer JC Scott Tuesday released the following statement on the Senate Finance Committee hearing, “Drug Pricing in America: A Prescription for Change, Part III:” “We applaud the Senate Finance Committee for holding toda

Bartell’s offers travel clinics for international trips

Around the world, health news is constantly changing. Whether it’s a new destination, or a road regularly traveled, international journeys can present health situations to those unaware of current circumstances.

Novartis completes spin-off of Alcon eye care devices business

Novartis Tuesday completed the spin-off of the Alcon eye care devices business through a dividend-in-kind distribution to holders of Novartis shares and ADRs (American Depositary Receipts), with each holder receiving 1 Alcon share for every 5 Novartis shares or ADRs held on April 8, 2019, at the clo